Frontlight ResearchEarly access
CompletedNo phase
Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China
Key facts
- Who runs it
- AbbVie
- Where
- China4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 100 people enrolled
- Started
- 17 Jul 2025
- Ended
- 13 Nov 2025
- Type of study
- Observational
- Record updated
- 19 November 2025
Who can take part
- Age
- 12 years to 99 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Male and female patients, age ≥ 12
- Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI<50) with or without facial involvement
- Medical history available within the last 6 months
- Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and < 18 years of age at inclusion visit)
- Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable
Who cannot take part
- Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment
- History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo
- Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection
- Segmental or localized vitiligo
- Greater than 33% leukotrichia in areas of vitiligo on the face or on the body
- Patients who are participating in interventional clinical trial(s) at time of study visit
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China
Read full original descriptionShow less
This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 19 November 2025